This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
286 |
4. Check minimum number of events
Min. number of events
3
|
286 |
5. Include endpointsNone |
286 |
6. Filter based on genotype QC (FinnGen only) |
286 |
Control definitions (FinnGen only)
- Control exclude
- RX_L04AB
Extra metadata
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
Infliximab
based on the number of shared cases.
Similar with more cases:
- Tumor necrosis factor alpha inhibitors
- Biological medication for rheuma
- ILD medications: immunosuppressive drugs
- ILD medications
- Any reimbursement code in KELA
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 286 | 151 | 135 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.06 |
| Median age at first event (years) | 44.31 | 45.61 | 42.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
249
9
2089.22
313.73
3.7
3.2
10.2
7.3
mg/l
—
232
9
178
58
79.62
294.75
1.7
1.7
1.5
0.0
iu/ml
—
40
7
148
119
24.70
164.83
1.7
1.4
—
—
—
0
0
67
24
36.15
102.24
1.2
1.2
—
—
—
0
0
256
809
21.63
95.33
3.7
2.3
72.4
72.3
nmol/l
0.02
250
758
270
1068
28.31
76.08
22.5
5.2
53.0
56.2
%
5.29
270
1024
270
1083
27.69
74.49
23.4
5.3
32.9
29.6
%
6.33
270
1040
169
421
8.37
73.68
3.3
1.9
2.5
2.9
mg/l
1.66
161
361
41
44
10.71
35.32
1.4
1.4
—
—
—
0
0
261
1593
8.30
30.34
10.6
3.3
11.5
8.3
mm/h
3.87
248
1489
58
113
6.18
29.76
1.2
1.4
—
—
—
0
0
77
217
4.49
25.55
2.3
2.1
23.3
24.7
%
0.34
68
192
286
2354
+∞
22.78
35.0
10.2
11.6
20.5
mg/l
14.10
271
1748
46
93
5.70
22.46
1.8
1.8
—
—
—
0
0
31
42
8.16
22.08
1.1
1.1
—
—
—
0
0
32
46
7.71
21.67
1.2
1.3
223.0
227.2
u/ml
0.03
20
27
25
27
10.05
21.17
1.4
1.6
—
—
—
0
0
25
27
10.05
21.17
1.4
1.6
—
—
—
0
0
25
27
10.05
21.17
1.4
1.6
—
—
—
0
0
25
28
9.69
20.61
1.4
1.5
—
—
—
0
0
25
28
9.69
20.61
1.4
1.5
—
—
—
0
0
25
28
9.69
20.61
1.4
1.5
—
—
—
0
0
25
29
9.35
20.07
1.8
2.8
1.3
2.1
%
0.44
19
24
182
1010
3.21
20.06
4.9
6.0
11.9
10.7
umol/l
0.58
176
968
31
51
6.70
18.53
1.2
1.2
—
—
—
0
0
286
2489
+∞
16.25
35.5
8.2
28.0
29.7
u/l
0.88
286
2430
20
23
9.27
16.08
1.8
2.6
52.6
63.1
%
1.20
14
17
128
643
2.79
15.90
1.9
1.7
93.5
97.6
pmol/l
0.52
98
330
140
804
2.45
12.43
4.4
3.3
29.2
33.4
u/l
1.20
132
767
23
42
5.87
12.33
1.0
1.2
—
—
—
0
0
22
40
5.88
11.84
7.4
3.0
4.1
4.5
e9/l
0.33
22
40
22
40
5.88
11.84
7.3
3.4
57.7
57.5
%
0.04
22
40
266
2141
4.47
11.07
22.1
8.6
98.3
95.3
ml/min/173m2
1.95
250
1729
13
17
7.96
9.35
1.2
1.1
—
—
—
0
0
13
17
7.96
9.35
1.2
1.1
—
—
—
0
0
16
30
5.59
8.30
1.3
1.4
—
—
—
0
0
266
2243
3.66
8.11
10.5
10.6
139.3
139.7
mmol/l
1.86
260
2189
15
27
5.81
8.11
1.5
1.1
—
—
—
0
0
266
2254
3.58
7.81
10.6
10.6
3.9
3.9
mmol/l
3.44
260
2189
156
1066
2.02
7.80
5.6
3.9
0.0
0.0
estimate
0.00
42
206
156
1079
1.98
7.40
4.6
2.9
0.1
0.0
estimate
0.49
39
192
13
23
5.87
7.13
1.2
1.3
—
—
—
0
0
119
757
1.98
7.12
2.8
6.3
1.2
1.2
mmol/l
1.25
110
706
154
1071
1.95
7.08
4.6
2.8
0.0
0.0
estimate
0.00
40
205
246
2032
2.51
7.01
35.4
12.4
13.6
13.4
%
1.18
246
2000
128
846
1.93
6.76
3.5
7.0
1.2
1.2
mmol/l
2.24
113
724
19
50
4.00
6.65
1.1
1.2
—
—
—
0
0
101
624
1.96
6.46
3.7
2.8
—
—
—
0
0
286
2703
+∞
6.36
43.3
15.1
138.7
139.8
g/l
0.78
286
2676
24
78
3.27
6.20
1.3
1.1
—
—
—
0
0
24
78
3.27
6.20
1.3
1.1
—
—
—
0
0
92
557
1.96
6.20
5.6
3.1
0.0
0.0
estimate
0.50
41
204
58
300
2.17
5.96
2.2
1.5
375.3
24723673.8
pmol/l
0.50
53
271
80
479
1.93
5.49
2.7
2.5
0.3
0.3
e6/l
0.21
64
357
5
0
+∞
5.22
1.4
0.0
—
—
—
0
0
68
392
1.96
5.18
1.4
1.3
13.8
20.9
iu/ml
1.00
18
116
35
155
2.43
5.14
4.1
2.3
80.2
76.6
ml/min/173m2
0.19
11
61
45
224
2.20
5.06
1.9
1.5
1057.6
1163.9
nmol/l
0.31
32
178
66
384
1.93
4.88
1.4
1.3
14.2
7.3
u/ml
0.36
22
173
36
172
2.25
4.46
1.6
1.3
—
—
—
0
0
33
156
2.26
4.19
10.2
13.3
1.0
1.2
inr
—
5
28
45
247
1.98
3.91
2.3
2.4
6.2
8.0
umol/l
0.39
39
205
7
8
8.93
3.79
1.4
1.7
—
—
—
0
0
87
590
1.68
3.78
1.4
1.3
0.8
1.0
u/ml
0.76
29
174
114
844
1.58
3.43
5.0
2.8
—
—
—
0
0
6
7
8.72
3.28
1.2
1.0
—
—
—
0
0
71
478
1.65
3.12
2.0
2.3
324.1
2959.8
umol/l
0.99
63
435
8
16
5.11
3.07
1.1
1.0
1342.0
1353.8
miu/ml
—
8
16
45
277
1.74
2.74
1.9
2.2
0.6
0.8
e6/l
0.53
27
151
42
256
1.75
2.64
2.0
2.4
1.0
3.2
e6/l
2.37
24
132
37
218
1.80
2.61
5.5
5.7
—
—
—
0
0
5
7
7.24
2.56
1.2
1.0
—
—
—
0
0
17
79
2.22
2.30
1.4
2.4
—
—
—
0
0
6
13
4.69
2.28
1.7
1.5
12.0
9.2
umol/l
—
6
13
252
2325
1.71
2.26
24.3
10.5
41.0
41.7
%
0.94
210
1945
8
25
3.26
2.11
1.0
1.1
—
—
—
0
0
18
89
2.09
2.11
2.0
1.6
—
—
—
0
0
6
16
3.81
1.94
1.0
1.1
—
—
—
0
0
61
444
1.48
1.86
1.6
1.5
—
—
—
0
0
23
135
1.77
1.68
1.4
1.5
200.1
282.7
miu/ml
—
9
73
6
20
3.04
1.59
1.0
1.2
—
—
—
0
0
18
101
1.83
1.53
1.5
1.4
—
—
—
0
0
9
43
2.13
1.31
1.6
2.9
—
—
—
0
0
6
24
2.53
1.31
1.0
1.8
—
—
—
0
0
8
34
2.39
1.30
1.0
4.7
—
4523.3
—
0
6
14
238
0.57
1.26
1.4
1.5
—
—
—
0
0
10
50
2.04
1.18
1.2
1.2
—
—
—
0
0
0
33
0.00
1.17
0.0
1.8
—
—
—
0
0
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
5
20
2.53
1.15
1.0
1.2
—
—
—
0
0
28
197
1.47
1.05
1.3
1.2
59.4
114.2
iu/ml
—
10
82
17
107
1.63
1.02
1.4
1.3
—
—
—
0
0
7
134
0.51
1.01
1.6
1.4
—
—
—
0
0
7
134
0.51
1.01
1.6
1.4
—
—
—
0
0
7
134
0.51
1.01
1.6
1.4
—
—
—
0
0
7
134
0.51
1.01
1.6
1.4
—
—
—
0
0
5
23
2.19
0.98
1.0
1.7
—
—
—
0
0
5
23
2.19
0.98
1.6
1.5
—
—
—
0
0
5
23
2.19
0.98
1.0
1.7
—
—
—
0
0
31
227
1.41
0.95
2.5
2.3
12.7
15.3
nmol/l
1.32
31
216
6
27
2.25
0.94
1.2
1.7
—
—
—
0
0
6
111
0.53
0.85
1.3
1.6
—
—
—
0
0
8
141
0.56
0.85
1.4
1.5
—
—
—
0
0
221
2091
1.25
0.83
3.5
3.7
—
—
—
0
0
13
82
1.61
0.79
1.2
1.7
—
—
—
0
0
7
38
1.86
0.74
4.1
3.1
3.2
3.3
u/ml
—
7
32
5
26
1.94
0.71
1.0
1.7
—
—
—
0
0
70
602
1.22
0.69
2.7
3.1
2.3
2.4
mmol/l
0.97
70
548
13
87
1.52
0.64
5.4
2.7
0.1
0.1
e6/l
0.08
13
82
7
113
0.61
0.59
1.3
3.4
5.3
5.1
kpa
—
7
105
80
708
1.18
0.58
2.0
1.6
—
—
—
0
0
75
667
1.17
0.52
2.7
2.7
10.2
28.6
ng/l
3.92
28
328
65
575
1.17
0.48
1.8
2.2
—
—
—
0
0
7
50
1.41
0.45
1.0
1.1
—
—
—
0
0
7
51
1.38
0.44
1.1
1.4
—
—
—
0
0
5
32
1.57
0.42
1.0
1.7
—
—
—
0
0
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
4.4
—
792.1
—
0
17
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
9
67
1.35
0.38
1.1
1.1
—
2.1
—
0
26
210
2167
0.88
0.38
3.2
3.2
1.3
1.3
mmol/l
0.40
205
2049
186
1932
0.89
0.37
3.9
4.2
36.2
38.0
mmol/mol
2.27
181
1845
30
350
0.84
0.36
2.7
2.9
18.6
23.1
%
—
10
100
55
495
1.14
0.33
1.4
1.8
0.6
0.8
mg/l
0.50
33
369
6
47
1.28
0.32
1.2
1.2
—
—
—
0
0
6
47
1.28
0.32
1.2
1.3
—
5.5
—
0
24
69
634
1.12
0.31
1.9
2.3
—
—
—
0
0
29
333
0.86
0.29
2.2
2.0
—
—
—
0
0
38
337
1.15
0.29
1.6
3.2
4.5
392.4
ng/l
2.45
17
197
11
140
0.78
0.29
2.4
1.7
—
—
—
0
0
10
76
1.33
0.28
1.9
2.2
—
—
—
0
0
11
139
0.78
0.27
2.3
13.1
118.8
125.5
g/l
0.70
11
130
13
160
0.80
0.26
1.5
1.4
—
—
—
0
0
222
2269
0.90
0.26
3.5
3.7
2.9
2.9
mmol/l
0.28
216
2146
5
71
0.70
0.26
1.8
11.9
23.2
24.3
mmol/l
—
5
64
9
75
1.21
0.25
2.4
2.3
53.4
55.5
%
—
9
75
184
1786
1.08
0.24
3.3
3.0
42.2
39.8
u/l
0.23
179
1725
205
2096
0.92
0.22
3.1
3.4
5.5
5.7
mmol/l
1.28
197
1974
13
156
0.83
0.22
2.0
6.6
1.2
1.3
mmol/l
0.18
13
149
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
49.4
—
0
11
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
24.0
—
0
10
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
10.5
—
62.3
—
0
7
31
339
0.90
0.17
1.5
1.6
—
—
—
0
0
17
149
1.15
0.16
1.1
1.0
—
—
—
0
0
23
254
0.90
0.15
1.7
2.1
0.5
0.6
ug/l
0.82
11
116
24
263
0.90
0.14
1.8
1.9
—
—
—
0
0
101
978
1.05
0.12
3.2
3.9
—
—
—
0
0
30
278
1.09
0.12
1.5
1.8
—
—
—
0
0
11
126
0.87
0.11
2.2
2.2
1.7
7.4
ug/l
3.86
11
119
228
2255
1.05
0.10
3.4
3.5
4.7
4.8
mmol/l
0.15
220
2147
6
58
1.04
0.08
1.8
1.6
—
—
—
0
0
177
1748
1.03
0.07
4.0
3.9
14.7
14.5
pmol/l
0.43
170
1639
8
78
1.03
0.07
2.1
2.0
—
—
—
0
0
7
83
0.84
0.07
1.4
1.2
—
—
—
0
0
35
336
1.05
0.05
2.4
2.7
276.5
564.9
ng/l
0.80
26
270
48
467
1.03
0.04
1.6
2.1
—
—
—
0
0
19
180
1.06
0.04
3.0
2.8
—
—
—
0
0
20
190
1.06
0.04
1.3
1.7
—
—
—
0
0
207
2083
0.98
0.03
4.4
4.4
1.6
2.3
mu/l
0.70
198
1969
224
2247
0.99
0.01
3.3
3.5
1.5
1.4
mmol/l
0.55
218
2133
45
452
0.99
0.00
1.3
1.9
1.3
1.4
%
0.57
38
416
13
131
0.99
0.00
1.7
1.7
—
—
—
0
0
18
185
0.97
0.00
1.3
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
7
78
0.89
0.00
1.3
2.3
102.4
94.6
%
—
7
78
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
8
87
0.92
0.00
1.9
2.1
0.9
1.6
%
—
8
87
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
9
96
0.94
0.00
1.8
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
524.7
—
0
6
0
6
0.00
0.00
0.0
2.0
—
57.5
—
0
6
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_L04AB02 – Infliximab
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).